Your browser doesn't support javascript.
Fertility Preservation in Female Patients with Cancer.
Mahmood, S; Drakeley, A; Homburg, R; Bambang, K.
  • Mahmood S; Liverpool Women's NHS Foundation Trust, Liverpool, UK. Electronic address: SarahMahmood100@gmail.com.
  • Drakeley A; Liverpool Women's NHS Foundation Trust, Liverpool, UK.
  • Homburg R; Homerton Fertility Centre, Homerton University Hospital NHS Foundation Trust, London, UK.
  • Bambang K; Liverpool Women's NHS Foundation Trust, Liverpool, UK.
Clin Oncol (R Coll Radiol) ; 34(8): 508-513, 2022 08.
Article in English | MEDLINE | ID: covidwho-1814269
ABSTRACT
Advances in cancer treatment with resultant dramatic improvements in long-term survival have led to increasing awareness of the wide range of medical and social issues faced by survivors of malignancy. The potential deleterious effects on fertility are a significant worry of women and trans gender men, and the rising trend in delaying childbearing and the higher proportion of patients who have not completed their family at the time of diagnosis increases the demand for an optimised fertility-preservation service. Fertility preservation for this group following a diagnosis of cancer is a rapidly expanding area of reproductive medicine, although provision for such treatment often varies by region. In the past, there were few treatment options, but with dramatic improvements in oocyte cryopreservation and, more recently, ovarian tissue cryopreservation, this area of fertility care has broadened substantially. This review will be exploring areas that apply to all cisgender women, but not necessarily all trans men and non-binary individuals. There are specific considerations in fertility preservation for trans people, which are beyond the scope of this paper. All individuals with female reproductive organs should be offered the opportunity to discuss fertility preservation prior to starting potential gonadotoxic treatment. Failure to do this may negatively influence their anticancer treatment choices and adherence to treatment regimens. There are currently few networks streamlined around offering this service and as demand for these treatment options increases, it is recognised that these complex patients require specialist management within recognised care pathways. Here we are looking to describe some of the unique challenges associated with providing a state-of-the-art service, particularly in a financially unpredictable climate in the midst of the COVID-19 pandemic.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fertility Preservation / COVID-19 / Neoplasms Type of study: Prognostic study Topics: Long Covid Limits: Female / Humans Language: English Journal: Clin Oncol (R Coll Radiol) Journal subject: Neoplasms Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Fertility Preservation / COVID-19 / Neoplasms Type of study: Prognostic study Topics: Long Covid Limits: Female / Humans Language: English Journal: Clin Oncol (R Coll Radiol) Journal subject: Neoplasms Year: 2022 Document Type: Article